ORM1 is an acute-phase protein, and increased ORM1 levels have been reported in the serum of patients with various malignant diseases, including hepatocellular carcinoma, gynecological carcinomas, esophageal cancer and head and neck cancers (21-24). Here, ORM1 is linked to hepatocellular carcinoma.